Literature DB >> 20085691

Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June - 31 December 2009.

T M van 't Klooster1, C C Wielders, T Donker, L Isken, A Meijer, C C van den Wijngaard, M A van der Sande, W van der Hoek.   

Abstract

We analysed and reported on a weekly basis clinical and epidemiological characteristics of patients hospitalised in the Netherlands for the 2009 pandemic influenza A(H1N1) using information from the national mandatory notification system. The notification criteria changed on 15 August 2009 from all possible, probable and confirmed cases to only laboratory-confirmed pandemic influenza hospitalisations and deaths. In the period of comprehensive case-based surveillance (until 15 August), 2% (35/1,622) of the patients with pandemic influenza were hospitalised. From 5 June to 31 December 2009, a total of 2,181 patients were hospitalised. Of these, 10% (219/2,181) were admitted to an intensive care unit (ICU) and 53 died. Among non-ICU hospitalised patients, 56% (961/1,722) had an underlying medical condition compared with 70% (147/211) of the patients in ICU and 46 of the 51 fatal cases for whom this information was reported. Most common complications were dehydration among non-ICU hospitalised patients and acute respiratory distress syndrome among patients in ICU and patients who died. Children under the age of five years had the highest age-specific hospitalisation rate (62.7/100,000), but relatively few were admitted to an ICU (1.7/100,000). Characteristics and admission rates of hospitalised patients were comparable with reports from other countries and previous influenza seasons. The national notification system was well suited to provide weekly updates of relevant monitoring information on the severity of the pandemic for professionals, decision makers, the media and the public, and could be rapidly adapted to changing information requirements.

Entities:  

Mesh:

Year:  2010        PMID: 20085691     DOI: 10.2807/ese.15.02.19461-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  39 in total

1.  Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers.

Authors:  Yi-Chun Lai; Kuen-Cheh Yang; Szu-Min Hsieh; Chien-An Yao; Long-Teng Lee; Kuo-Chin Huang
Journal:  Clin Vaccine Immunol       Date:  2012-01-18

Review 2.  Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Authors:  Anandi N Sheth; Keri N Althoff; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

3.  Surveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010-2011.

Authors:  René Snacken; Chantal Quinten; Isabelle Devaux; Flaviu Plata; Eeva Broberg; Phillip Zucs; Andrew Amato-Gauci
Journal:  Influenza Other Respir Viruses       Date:  2012-07-13       Impact factor: 4.380

Review 4.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China.

Authors:  Wei Cui; Hongwen Zhao; Xu Lu; Ying Wen; Ying Zhou; Baocheng Deng; Yu Wang; Wen Wang; Jian Kang; Pei Liu
Journal:  BMC Infect Dis       Date:  2010-05-31       Impact factor: 3.090

6.  Registry-based surveillance of influenza-associated hospitalisations during the 2009 influenza pandemic in Denmark: the hidden burden on the young.

Authors:  Katarina Widgren; Jens Nielsen; Kåre Mølbak
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

7.  Effective influenza vaccines for children: a critical unmet medical need and a public health priority.

Authors:  Angelika Banzhoff; Jeffrey J Stoddard
Journal:  Hum Vaccin Immunother       Date:  2012-02-13       Impact factor: 3.452

8.  Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands.

Authors:  Arianne B van Gageldonk-Lafeber; Marianne Ab van der Sande; Adam Meijer; Ingrid Hm Friesema; Gé A Donker; Johan Reimerink; Mirna Robert-Du Ry van Beest Holle; Jan M Prins; Leslie Isken; François G Schellevis; Mariken Im van der Lubben
Journal:  Antimicrob Resist Infect Control       Date:  2012-09-21       Impact factor: 4.887

9.  Estimating age-specific influenza-related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN.

Authors:  Astride Jules; Carlos G Grijalva; Yuwei Zhu; Keipp H Talbot; John V Williams; William D Dupont; Kathryn M Edwards; William Schaffner; David K Shay; Marie R Griffin
Journal:  Influenza Other Respir Viruses       Date:  2012-02-23       Impact factor: 4.380

10.  The impact of sex, gender and pregnancy on 2009 H1N1 disease.

Authors:  Sabra L Klein; Catherine Passaretti; Martha Anker; Peju Olukoya; Andrew Pekosz
Journal:  Biol Sex Differ       Date:  2010-11-04       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.